Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Sales | 16,142 | 31,408 | 158 | 382 | 175 |
| Gross Profit | 16,142 | 31,408 | 158 | 382 | 175 |
| Operating Expenses | 72,079 | 68,404 | 81,901 | 96,356 | 53,451 |
| Operating Income | -55,936 | -36,996 | -81,743 | -95,974 | -53,276 |
| Other Income | 1,488 | 2,618 | 22 | 4,036 | -5,444 |
| Pre-tax Income | -54,448 | -34,378 | -81,721 | -91,939 | -58,720 |
| Income Tax | 2 | 2 | -2 | -2 | -5 |
| Net Income Continuous | -54,451 | -34,380 | -81,718 | -91,936 | -58,715 |
| Minority Interests | N/A | N/A | N/A | N/A | -95 |
| Net Income | $-54,451 | $-34,380 | $-81,723 | $-91,941 | $-58,630 |
| EPS Basic Total Ops | -0.65 | -0.47 | -1.34 | -1.60 | -1.25 |
| EPS Basic Continuous Ops | -0.65 | -0.47 | -1.34 | -1.60 | -1.25 |
| EPS Diluted Total Ops | -0.65 | -0.47 | -1.34 | -1.60 | -1.25 |
| EPS Diluted Continuous Ops | -0.65 | -0.47 | -1.34 | -1.60 | -1.25 |
| EPS Diluted Before Non-Recurring Items | -0.65 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-50,854 | $-32,349 | $-78,251 | $-92,527 | $-51,137 |